An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection - Wikidata - wikimedia - TriplyDB

An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection

An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection

http://www.wikidata.org/entity/Q24646809

about

sameAs

Lactobacillus species as biomarkers and agents that can promote various aspects of vaginal health HSV-2: in pursuit of a vaccine Episodic therapy for recurrent genital herpes in non-immunocompromized adults Oral antiviral therapy for prevention of genital herpes outbreaks in immunocompetent and nonpregnant patients Antiviral therapy for genital herpes for prevention of HIV transmission Human Herpesviruses as Copathogens of HIV Infection, Their Role in HIV Transmission, and Disease Progression Infectious co-factors in HIV-1 transmission herpes simplex virus type-2 and HIV-1: new insights and interventions Multipurpose prevention technologies: the future of HIV and STI protection Herpes simplex epithelial and stromal keratitis: an epidemiologic update Structural basis for the antibody neutralization ofHerpes simplex virus Incidence of herpes simplex virus type 2 infections in Africa: a systematic review Daily oral emtricitabine/tenofovir preexposure prophylaxis and herpes simplex virus type 2 among men who have sex with men Herpes genitalis and the philosopher's stance.Sexual, Reproductive Health Needs, and Rights of Young People in Slum Areas of Kampala, Uganda: A Cross Sectional Study.Virologic and immunologic evidence of multifocal genital herpes simplex virus 2 infection.Smart Cup: A Minimally-Instrumented, Smartphone-Based Point-of-Care Molecular Diagnostic Device.Comparison of the vaginal microbial communities in women with recurrent genital HSV receiving acyclovir intravaginal rings.Effectiveness of Early Antiviral Therapy in Disseminated Neonatal Herpes Simplex Virus 2 (HSV-2) with Fulminant Hepatic Failure.Low prevalence of varicella zoster virus and herpes simplex virus type 2 in saliva from human immunodeficiency virus-infected persons in the era of highly active antiretroviral therapy.Antibody to HSV gD peptide induced by vaccination does not protect against HSV-2 infection in HSV-2 seronegative women Mucosal treatments for herpes simplex virus: insights on targeted immunoprophylaxis and therapy Construction and properties of a herpes simplex virus 2 dl5-29 vaccine candidate strain encoding an HSV-1 virion host shutoff protein.Population level impact of an imperfect prophylactic vaccine for herpes simplex virus-2 Risk Factors for HSV-2 Infection among Sexual Partners of HSV-2/HIV-1 Co-Infected Persons.Validation of the modes of transmission model as a tool to prioritize HIV prevention targets: a comparative modelling analysis.Current status and prospects for development of an HSV vaccine Associations of HLA-A, HLA-B and HLA-C alleles frequency with prevalence of herpes simplex virus infections and diseases across global populations: implication for the development of an universal CD8+ T-cell epitope-based vaccine.Email interviewing: generating data with a vulnerable population.Seroprevalence and risk factors of herpes simplex virus type-2 infection among pregnant women in Northeast India.Role of HSV-2 suppressive therapy for HIV prevention.A Bayesian approach to uncertainty analysis of sexually transmitted infection models.Mucosal immunity in the female genital tract, HIV/AIDS High-purity preparation of HSV-2 vaccine candidate ACAM529 is immunogenic and efficacious in vivo Deciphering the epidemic synergy of herpes simplex virus type 2 (HSV-2) on human immunodeficiency virus type 1 (HIV-1) infection among women in sub-Saharan Africa.The need for multipurpose prevention technologies in sub-Saharan Africa.Vaccine delivery by polymeric vehicles in the mouse reproductive tract induces sustained local and systemic immunity Immunogenicity and efficacy of intramuscular replication-defective and subunit vaccines against herpes simplex virus type 2 in the mouse genital model Loss of the type I interferon pathway increases vulnerability of mice to genital herpes simplex virus 2 infection.Anti-glycoprotein g antibodies of herpes simplex virus 2 contribute to complete protection after vaccination in mice and induce antibody-dependent cellular cytotoxicity and complement-mediated cytolysis Crystal structure of herpes simplex virus 2 gD bound to nectin-1 reveals a conserved mode of receptor recognition.

P2860

Q21129223-0C97B52F-3E70-4B8B-9A77-6CE8B6B82F6F Q22306291-653E323C-FF84-439D-AFAB-36A831674081 Q24187642-7EFE756D-ADFD-4376-AB42-789243D2B4FC Q24194490-620B8D7E-CE41-4BC2-B9DF-E88F4EAC73FF Q24234315-BBF5B1B7-D167-40C2-9448-BDC8FE00DE48 Q26751304-943727D0-EBDA-413B-B4FA-7553AAE98BD8 Q26823594-6FA0DA4E-294A-4722-9CC0-553CB4E431F0 Q26827796-8152E0F0-9C6C-4AC1-B1B4-2EA4C22AB197 Q26853504-60323601-529E-4AAD-AC2B-DABE27318337 Q27680164-CD66B14D-E64F-4D4A-8DFF-1A672B4ECB6C Q27690876-2E53853A-5DD8-46B1-8AF7-1E528A11B1E1 Q28540969-E526B632-7D32-40FB-9069-FD9F2C99F975 Q30357939-EAC21AB8-C371-4EA8-9168-E0E760620649 Q30379023-B504418F-F101-4E11-9A8D-C340F2784D0D Q30576590-7524E488-B95F-4E3D-815E-4090903522FE Q33447347-5889EB6A-6CFE-4C64-B17E-4FF5F72C53D2 Q33554048-0C6086A9-3DA5-4FEB-99E9-7CF45E8C310F Q33574240-07974058-D814-4034-97EF-0D31692721A3 Q33636301-453E52CE-9B4B-4645-AA71-AF6CCEF65493 Q33663463-C3D89FC8-FBBE-47C3-8AF4-2D60973B20F5 Q33710019-0F38A835-0B6A-4501-89FE-48562BD03A63 Q33724497-5E0C3F23-06E2-4013-B651-8976636522BA Q33812029-5C7CC55E-AB28-4D64-AD27-B753C6E33249 Q33846603-2EB11734-0334-4C13-869B-C0F7CE3F5992 Q33875146-888008EF-3DA0-4BCD-87E8-4FC6AC34A9B4 Q33931016-A805D2B0-7FF5-40B4-A83A-36B3E621C2AB Q33993731-11771DE5-EE3C-42AC-8F48-B9D9E2742424 Q34048232-AEAA06A9-47C9-4D72-8E44-326BD7A32C25 Q34082025-D47A6EDA-16A7-4327-A436-6A9634A4BA83 Q34184590-689B01E8-F62B-4C5B-91F3-45EE9E431616 Q34191683-DAA24B32-24E1-46FC-8FFB-F3BEFC0508E9 Q34275424-DA43B339-6741-4244-8FD9-7C213CCF30B4 Q34331569-C747ECA0-679B-42BB-955B-F88F4AAB6112 Q34386832-C028E2A0-4495-4ACA-B400-0FE83841D214 Q34390282-8FC3BB55-79C7-405C-8B10-74355B0AD349 Q34415303-159CA281-EEAB-40AD-8B72-3EDE0C0805F0 Q34447379-6F89FA80-0149-4B12-A6D7-6C920B359761 Q34529742-399BACB6-AC22-4F46-A830-0924A55D8338 Q34580831-41CFEE51-B1F4-48DE-9361-07898670E513 Q34594121-5A10F994-B5AA-421F-A6F8-BE437D7E2E94

P2860

An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection

http://www.wikidata.org/entity/Q24646809

description

2008 nî lūn-bûn

@nan

2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

An estimate of the global prev ...... simplex virus type 2 infection

@ast

An estimate of the global prev ...... simplex virus type 2 infection

@en

An estimate of the global prev ...... simplex virus type 2 infection

@nl

type

label

An estimate of the global prev ...... simplex virus type 2 infection

@ast

An estimate of the global prev ...... simplex virus type 2 infection

@en

An estimate of the global prev ...... simplex virus type 2 infection

@nl

prefLabel

An estimate of the global prev ...... simplex virus type 2 infection

@ast

An estimate of the global prev ...... simplex virus type 2 infection

@en

An estimate of the global prev ...... simplex virus type 2 infection

@nl

P1433

Q24646809-38B51BBE-8815-4825-BC6F-2E984C99894E

P1476

Q24646809-E536CFAB-5577-4B86-A223-6562CE4BC48E

P2093

Q24646809-839A2F32-971F-42A8-944C-F61F1BC59848

Q24646809-BF78060B-59CA-4116-BA93-B5817EC62DF7

Q24646809-EEA93C96-5733-410F-9587-D27FB1CDE21A

P2860

Q24646809-06341052-D164-4CEB-944D-B44F89765EF9

Q24646809-10743FB7-FA77-4BE4-9B43-47F8F187FBCB

Q24646809-1EF9A885-1F3F-4146-B1CA-4552A386706B

Q24646809-2C5DC55C-0D5A-45A7-931F-22E1168AD35C

Q24646809-2F6DA8B3-023B-4E29-9278-B5FA01092842

Q24646809-305A5B9D-B023-43F4-B1FC-5C0783B7F9B9

Q24646809-3487A38D-7D72-4BAD-B9F5-4B7F425CE3CF

Q24646809-355F3EE7-2071-4E2A-8992-EBB729B7DBD3

Q24646809-36E5DFA4-7A45-42F2-AEA4-18F32132CD3C

Q24646809-372DCB43-68B9-4805-949C-398F09E69C2F

P304

Q24646809-CA69702E-D11F-492E-AA68-41DC536415ED

P31

Q24646809-F38E8E43-9423-46B6-A37B-8176E5BC81CC

P3181

Q24646809-0ADCBDB8-EB60-47AD-8259-603ECF5EFFBB

P356

Q24646809-E7DCEB20-D201-4B99-AFBF-7C41ED6DC2E1

P407

Q24646809-6CAACC43-90E5-46E7-8F94-FD38691E64A7

P433

Q24646809-62E101F9-BF07-43E5-A6C5-5AF903B28A52

P478

Q24646809-83F2BB7B-8C9C-4B9D-8DEC-74F2ADE9285F

P577

Q24646809-079C5EAB-3851-4118-83C5-F18B7F6ED963

P698

Q24646809-4B952451-1168-4936-8B0B-C114365E5E35

P921

Q24646809-042519C8-D8EB-4DAD-A6B5-372127FF8B93

P932

Q24646809-FA8C3BCC-7B74-4A68-AAEE-DEE5FB808265

P3181

P356

P1433

Bulletin of the World Health Organization

P1476

An estimate of the global prev ...... simplex virus type 2 infection

@en

P2093

Geoffrey P Garnett

http://www.w3.org/2001/XMLSchema#string

George P Schmid

http://www.w3.org/2001/XMLSchema#string

Katharine J Looker

http://www.w3.org/2001/XMLSchema#string

P2860

The seroepidemiology of herpes simplex virus type 1 and 2 in Europe

Seroepidemiology of Herpes Simplex virus type 1 and 2 in Western and Southern Switzerland in adults aged 25-74 in 1992-93: a population-based study

Young age at first sexual intercourse and sexually transmitted infections in adolescents and young adults

Recurrences after oral and genital herpes simplex virus infection. Influence of site of infection and viral type

Global prevalence and incidence estimates of selected curable STDs.

Seroprevalence of HSV-1 and HSV-2 infection in the general French population.

Longitudinal study of genital infection by herpes simplex virus type 1 in Western Scotland over 15 years

Prospects for control of herpes simplex virus disease through immunization.

Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review.

Increasing proportion of herpes simplex virus type 1 as a cause of genital herpes infection in college students.

P304

805-812

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1840857

http://www.w3.org/2001/XMLSchema#string

P356

10.2471/BLT.07.046128

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

86

http://www.w3.org/2001/XMLSchema#string

P577

2008-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18949218

http://www.w3.org/2001/XMLSchema#string

P921

P932

2649511

http://www.w3.org/2001/XMLSchema#string